The Deininger lab expertise is in the translational research of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecular targeted therapies. We are especially interested in developing novel anti-neoplastic targeted therapies in myeloid leukemia, as well as understanding the molecular mechanisms of cancer stem cell persistence and leukemia drug resistance.
Our lab orchestrates a multi-disciplinary cancer research program, straddling genetics, biochemistry, molecular biology, pharmacology, and biomedical engineering. We are proud of our vibrant team of scientists who strive to improve the diagnosis, deep analysis, and therapeutics of myeloid leukemia.
